Recent Updates
Recently added Catalysts
STVN Positive Sentiment

Stevanato Group to Participate in Two Upcoming Investor Conferences

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Stevanato Group S.p.A. (NYSE: STVN) has announced its participation in two significant investor conferences. The first will be held on September 15 at the Morgan Stanley Annual Global Healthcare Conference in New York, followed by the BofA Global Healthcare Conference on September 22. These events aim to strengthen investor relations and showcase the company's offerings.

Market Sentiment Analysis

POSITIVE FACTORS

  • Stevanato Group is actively engaging with investors.
  • Participation in major healthcare conferences enhances visibility.
  • The company is recognized as a leader in drug delivery solutions.

Full Press Release Details

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences: Tuesday, September 15, at 1:50 p.m. (ET) – Morgan Stanley Annual Global Healthcare Conference, New York, NY Tuesday, September 22, at 8:25 – 9:05 a.m. (GMT) – BofA Global Healthcare Confere

Frequently Asked Questions

When will Stevanato Group participate in the conferences?

Stevanato Group will participate on September 15 and September 22, 2023.

What is the location of the Morgan Stanley conference?

The Morgan Stanley Annual Global Healthcare Conference will be in New York, NY.

What is the purpose of these investor conferences?

The conferences aim to enhance investor relations and showcase Stevanato's solutions.

What time is Stevanato's presentation at the BofA conference?

Stevanato's presentation at the BofA conference is scheduled from 8:25 to 9:05 a.m. GMT.

ShareAdd on Google
Tags: STVN Viatris Investor Conferences Healthcare Stevanato Group investor conferences healthcare conference drug delivery
Last updated: Sep 8, 2026